EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19 (EPI CV COVID)

University Hospital Center (CHU) Dijon Bourgogne

Status: Unknown

Conditions: Acute Myocardial Infarction

Treatments: Biological: Biological data; Other: Clinical data

Study type: Observational

Funder types: Other

Identifiers

NCT04498091

Zeller AOIc 2020

Details and patient eligibility

About

The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without pneumonia
• patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without COVID 19

Exclusion criteria

• None

Trial design

35 participants in 4 patient groups

A

Description:

Type 2 MI with COVID-19

Treatment:

Biological: Biological data

Other: Clinical data

B

Description:

Type 2 without COVID-19

Treatment:

Biological: Biological data

Other: Clinical data

C

Description:

Type 2 MI with pneumonia without COVID-19

Treatment:

Biological: Biological data

Other: Clinical data

D

Description:

Type 2 MI without pneumonia and without COVID-19

Treatment:

Biological: Biological data

Other: Clinical data